Search Within

Charlene Claire Kabel

Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
  3. Review (2)
Groups
  1. Clinical Pharmacy Specialists (15)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Adult Leukemia (12)
  6. Weinberg Fellows (6)

More Groups

People
  1. Mark Geyer (6)
  2. Anthony Mato (5)
  3. Jae Park (5)
  4. Lindsey Roeker (5)
  5. Martin Tallman (5)
  6. Sarah Stump (5)

More People

Years
  1. 2024 (3)
  2. 2022 (2)
  3. 2021 (1)
  4. 2019 (8)
  5. 2018 (1)
Publications
  1. Blood (5)
  2. Annals of Pharmacotherapy (1)
  3. Blood Advances (1)
  4. Clinical Cancer Research (1)
  5. Clinical Lymphoma, Myeloma and Leukemia (1)
  6. European Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Elsevier Ltd (1)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Inc. (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pegaspargase can safely be administered in adults age 40 and older with acute lymphoblastic leukemia
    Meeting Abstract

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Blood (2019)

    Fulltext@MSK | Save
  • No loose ends: A review of the pharmacotherapy of hairy cell and hairy cell leukemia variant
    Review

    King, A. C.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Daley, R. J.
    Annals of Pharmacotherapy (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Tumor lysis, adverse events, and dose adjustments in 297 venetoclax-treated CLL patients in routine clinical practice
    Journal Article

    Roeker, L. E.; Fox, C. P.; Eyre, T. A.; Brander, D. M.; Allan, J. N.; Schuster, S. J.; Nabhan, C.; Hill, B. T.; Shah, N. N.; Lansigan, F.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Evidence for and against green tea and turmeric in the management of chronic lymphocytic leukemia
    Journal Article

    Bange, E.; Timlin, C.; Kabel, C.; Svoboda, J.; Roeker, L.; Mato, A. R.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save